OPEN END TURBO OHNE STOP-LOSS - INNOCAN PHARMA Share Price

Certificat

DE000LX21J38

Market Closed - Börse Stuttgart 07:09:40 14/06/2024 BST
0.1 EUR 0.00% Intraday chart for OPEN END TURBO OHNE STOP-LOSS - INNOCAN PHARMA
1 month-9.09%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
14/06/24 0.1 0.00%
13/06/24 0.1 0.00%
11/06/24 0.1 0.00%
10/06/24 0.1 0.00%
07/06/24 0.1 0.00%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 07:09 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying INNOCAN PHARMA CORPORATION
Issuer Lang & Schwarz
WKN LX21J3
ISINDE000LX21J38
Date issued 05/04/2023
Strike 0.1
Maturity Unlimited
Parity 1 : 1
Emission price 0.09
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.23
Lowest since issue 0.037

Company Profile

Innocan Pharma Corporation is an Israel-based pharmaceutical company active in the medical cannabis industry. It operates through three distinct operating segments: Research, Development, Marketing, Distribution and sales of InnoCan-branded over the counter (OTC) pharmaceutical products; Research and Development of Non-pharmaceutical products for third parties and Research and Development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales. The Company is developing an OTC topical treatments product line and new platform to facilitate the targeted controlled administration of cannabinoids via injection.
Sector
-
More about the company

Consensus: InnoCan Pharma Corporation

Sell
Consensus
Buy
Mean consensus
Number of Analysts
0
Last Close Price
0.27
Average target price
-
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW